A detailed history of Zeke Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 24,908 shares of MRK stock, worth $2.44 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
24,908
Previous 26,645 6.52%
Holding current value
$2.44 Million
Previous $2.3 Million 20.39%
% of portfolio
0.18%
Previous 0.17%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $151,883 - $194,735
-1,737 Reduced 6.52%
24,908 $2.76 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $338 - $379
-4 Reduced 0.02%
26,645 $2.3 Million
Q2 2022

Aug 09, 2022

SELL
$83.49 - $94.64 $264,830 - $300,198
-3,172 Reduced 10.64%
26,649 $2.43 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $1.03 Million - $1.16 Million
14,065 Added 89.27%
29,821 $2.45 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $62,594 - $78,407
-866 Reduced 5.21%
15,756 $1.21 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $54,333 - $59,753
758 Added 4.78%
16,622 $1.25 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $5,624 - $6,221
-80 Reduced 0.5%
15,864 $1.23 Million
Q1 2021

Apr 21, 2021

SELL
$68.86 - $81.11 $276,404 - $325,575
-4,014 Reduced 20.11%
15,944 $1.23 Million
Q4 2020

Feb 10, 2021

BUY
$71.77 - $79.65 $272,367 - $302,271
3,795 Added 23.48%
19,958 $1.63 Million
Q3 2020

Nov 09, 2020

SELL
$73.18 - $82.95 $70,472 - $79,880
-963 Reduced 5.62%
16,163 $1.34 Million
Q2 2020

Jul 21, 2020

SELL
$70.42 - $80.13 $320,270 - $364,431
-4,548 Reduced 20.98%
17,126 $1.32 Million
Q1 2020

Apr 24, 2020

SELL
$63.36 - $87.82 $141,166 - $195,662
-2,228 Reduced 9.32%
21,674 $1.67 Million
Q4 2019

Jan 17, 2020

SELL
$77.58 - $87.54 $108,534 - $122,468
-1,399 Reduced 5.53%
23,902 $2.17 Million
Q3 2019

Oct 18, 2019

BUY
$76.08 - $82.93 $273,507 - $298,133
3,595 Added 16.56%
25,301 $2.13 Million
Q2 2019

Jul 24, 2019

BUY
$69.84 - $81.59 $26,748 - $31,248
383 Added 1.8%
21,706 $1.82 Million
Q1 2019

Apr 29, 2019

SELL
$69.58 - $79.36 $269,413 - $307,281
-3,872 Reduced 15.37%
21,323 $1.77 Million
Q4 2018

Feb 11, 2019

SELL
$65.24 - $75.71 $4.71 Million - $5.46 Million
-72,126 Reduced 74.11%
25,195 $1.93 Million
Q3 2018

Nov 08, 2018

SELL
$57.69 - $67.84 $34,556 - $40,636
-599 Reduced 0.61%
97,321 $6.9 Million
Q2 2018

Jul 24, 2018

BUY
$50.83 - $59.72 $572,396 - $672,506
11,261 Added 12.99%
97,920 $5.94 Million
Q1 2018

May 03, 2018

BUY
$50.96 - $59.23 $676,544 - $786,337
13,276 Added 18.09%
86,659 $4.72 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $24,519 - $29,279
475 Added 0.65%
73,383 $4.13 Million
Q3 2017

Nov 09, 2017

BUY
$58.67 - $63.13 $4.28 Million - $4.6 Million
72,908
72,908 $4.67 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Zeke Capital Advisors, LLC Portfolio

Follow Zeke Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.